{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:05:46Z","timestamp":1777341946411,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04683-7","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:02:23Z","timestamp":1700733743000},"page":"3913-3920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of radiotherapy in the management of squamous cell cancer of the penis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0711-3318","authenticated-orcid":false,"given":"Juanita","family":"Crook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"4683_CR1","doi-asserted-by":"publisher","DOI":"10.2196\/34874","volume":"8","author":"L Fu","year":"2022","unstructured":"Fu L, Tian T, Yao K, Chen X, Luo G, Gao Y, Lin Y, Wang B, Sun Y, Zheng W, Li P, Zhan Y, Fairley CK, Grulich A, Zou H (2022) Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study. JMIR Public Health Surveill 8:e34874. https:\/\/doi.org\/10.2196\/34874","journal-title":"JMIR Public Health Surveill"},{"key":"4683_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00345-011-0802-0","volume":"31","author":"A Chaux","year":"2013","unstructured":"Chaux A, Netto GJ, Rodr\u00edguez I, M., Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Xavier Bosch F, de Sanjose S, Mu\u00f1oz N, Hildesheim A, Cubilla AL, (2013) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31:861\u2013867. https:\/\/doi.org\/10.1007\/s00345-011-0802-0","journal-title":"World J Urol"},{"key":"4683_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, Munk C, Kj\u00e6r SK (2019) Prevalence of human papillomavirus DNA and p16 INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol 20:145\u2013158. https:\/\/doi.org\/10.1016\/S1470-2045(18)30682-X","journal-title":"Lancet Oncol"},{"key":"4683_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/jmv.24670","volume":"89","author":"H Liu","year":"2017","unstructured":"Liu H, Li J, Zhou Y, Hu Q, Zeng Y, Mohammadreza MM (2017) Human papillomavirus as a favorable prognostic factor in a subset of head and neck squamous cell carcinomas: A meta-analysis. J Med Virol 89:710\u2013725. https:\/\/doi.org\/10.1002\/jmv.24670","journal-title":"J Med Virol"},{"key":"4683_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1158\/1055-9965.EPI-19-1259","volume":"29","author":"A Urbute","year":"2020","unstructured":"Urbute A, Rasmussen CL, Belmonte F, Obermueller T, Prigge E, Arbyn M, Verdoodt F, Kjaer SK (2020) Prognostic Significance of HPV DNA and p16 INK4a in Anal Cancer: A Systematic Review and Meta-Analysis. Cancer Epidemiol Biomarkers Prev 29:703\u2013710. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-1259","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4683_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","volume":"152","author":"FL Sand","year":"2019","unstructured":"Sand FL, Nielsen DMB, Frederiksen MH, Rasmussen CL, Kjaer SK (2019) The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis. Gynecol Oncol 152:208\u2013217. https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.015","journal-title":"Gynecol Oncol"},{"key":"4683_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","volume":"4","author":"M Bandini","year":"2021","unstructured":"Bandini M, Ross JS, Zhu Y, Ye D, Ornellas AA, Watkin N, Ayres BA, Hakenberg OW, Heidenreich A, Salvioni R, Catanzaro M, Raggi D, Giannatempo P, Marandino L, Haidl F, Pederzoli F, Briganti A, Montorsi F, Chipollini J, Azizi M, De Meerleer G, Brouwer OR, Grass GD, Johnstone PA, Albersen M, Spiess PE, Necchi A (2021) Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma. Eur Urol Oncol 4:802\u2013810. https:\/\/doi.org\/10.1016\/j.euo.2020.10.011","journal-title":"Eur Urol Oncol"},{"key":"4683_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.brachy.2022.06.005","volume":"21","author":"A Rishi","year":"2022","unstructured":"Rishi A, Saini AS, Spiess PE, Yu A, Fernandez DC, Johnstone PAS, Naghavi AO (2022) Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer. Brachytherapy 21:839\u2013847. https:\/\/doi.org\/10.1016\/j.brachy.2022.06.005","journal-title":"Brachytherapy"},{"key":"4683_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brachy.2009.05.005","volume":"9","author":"J Crook","year":"2010","unstructured":"Crook J, Jezioranski J, Cygler JE (2010) Penile brachytherapy: technical aspects and postimplant issues. Brachytherapy 9:151\u2013158. https:\/\/doi.org\/10.1016\/j.brachy.2009.05.005","journal-title":"Brachytherapy"},{"key":"4683_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.brachy.2013.01.167;10.1016\/j.brachy.2013.01.167","volume":"12","author":"JM Crook","year":"2013","unstructured":"Crook JM, Haie-Meder C, Demanes DJ, Mazeron JJ, Martinez AA, Rivard MJ (2013) American Brachytherapy Society-Groupe Europeen de Curietherapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy 12:191\u2013198. https:\/\/doi.org\/10.1016\/j.brachy.2013.01.167;10.1016\/j.brachy.2013.01.167","journal-title":"Brachytherapy"},{"key":"4683_CR11","unstructured":"Crook J, Chargari C (2022) The GEC ESTRO Handbook of Brachytherapy | Part II Clinical Practice | Chapter 22 Penis Cancer, Second Edition:1\u201314"},{"key":"4683_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.brachy.2011.01.009;10.1016\/j.brachy.2011.01.009","volume":"10","author":"A Gomez-Iturriaga","year":"2011","unstructured":"Gomez-Iturriaga A, Crook J, Evans W, Saibishkumar EP, Jezioranski J (2011) The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy. Brachytherapy 10:491\u2013497. https:\/\/doi.org\/10.1016\/j.brachy.2011.01.009;10.1016\/j.brachy.2011.01.009","journal-title":"Brachytherapy"},{"key":"4683_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.clon.2006.01.004","volume":"18","author":"M Azrif","year":"2006","unstructured":"Azrif M, Logue JP, Swindell R, Cowan RA, Wylie JP, Livsey JE (2006) External-beam radiotherapy in T1\u20132 N0 penile carcinoma. Clin Oncol (R Coll Radiol) 18:320\u2013325","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4683_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/j.1464-410X.2007.07168.x","volume":"100","author":"T Mistry","year":"2007","unstructured":"Mistry T, Jones RW, Dannatt E, Prasad KK, Stockdale AD (2007) A 10-year retrospective audit of penile cancer management in the UK. BJU Int 100:1277\u20131281","journal-title":"BJU Int"},{"key":"4683_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rpor.2019.09.006","volume":"24","author":"Z Yuan","year":"2019","unstructured":"Yuan Z, Grass GD, Azizi M, Ahmed KA, Yoder GS, Welsh EA, Fulp WJ, Dhillon J, Torres-Roca J, Giuliano AR, Spiess PE, Johnstone PA (2019) Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy. Rep Pract Oncol Radiother 24:593\u2013599. https:\/\/doi.org\/10.1016\/j.rpor.2019.09.006","journal-title":"Rep Pract Oncol Radiother"},{"key":"4683_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.02.027","author":"OR Brouwer","year":"2023","unstructured":"Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fern\u00e1ndez-Pello S, Greco I, van der Heijden M, S., Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Garcia-Perdomo H, Rumble RB, Sachdeva A, Sakalis VI, Zapala \u0141, S\u00e1nchez Mart\u00ednez D, F., Spiess PE, Tagawa ST, (2023) European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027","journal-title":"Eur Urol"},{"key":"4683_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00432-022-04012-2","volume":"148","author":"CD Fankhauser","year":"2022","unstructured":"Fankhauser CD, de Vries H, M., Roussel E, Jakobsen JK, Issa A, Lee EWC, Schifano N, Alnajjar H, Castiglione F, Antonelli L, Oliveira P, Lau M, Parnham A, Albersen M, Watkin NA, Muneer A, Ayres BE, Brouwer OR, Sangar V, (2022) Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer. J Cancer Res Clin Oncol 148:2231\u20132234. https:\/\/doi.org\/10.1007\/s00432-022-04012-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"4683_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015;10.1016\/j.eururo.2010.08.015","volume":"58","author":"NM Graafland","year":"2010","unstructured":"Graafland NM, Lam W, Leijte JA, Yap T, Gallee MP, Corbishley C, van Werkhoven E, Watkin N, Horenblas S (2010) Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol 58:742\u2013747. https:\/\/doi.org\/10.1016\/j.eururo.2010.08.015;10.1016\/j.eururo.2010.08.015","journal-title":"Eur Urol"},{"key":"4683_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bju.15700","volume":"130","author":"EWC Lee","year":"2022","unstructured":"Lee EWC, Issa A, Oliveira P, Lau M, Sangar V, Parnham A, Fankhauser CD (2022) High diagnostic accuracy of inguinal ultrasonography and fine-needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes. BJU Int 130:331\u2013336. https:\/\/doi.org\/10.1111\/bju.15700","journal-title":"BJU Int"},{"key":"4683_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/bju.15725","volume":"130","author":"L Wever","year":"2022","unstructured":"Wever L, de Vries H, M., Dell\u2019Oglio P, van der Poel H, G., Donswijk ML, Sikorska K, van Leeuwen F, W.B., Horenblas S, Brouwer OR, (2022) Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer. BJU Int 130:486\u2013495. https:\/\/doi.org\/10.1111\/bju.15725","journal-title":"BJU Int"},{"key":"4683_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.eururo.2007.01.107","volume":"52","author":"JAP Leijte","year":"2007","unstructured":"Leijte JAP, Kroon BK, Vald\u00e9s Olmos R, A., Nieweg OE, Horenblas S, (2007) Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 52:170\u2013177. https:\/\/doi.org\/10.1016\/j.eururo.2007.01.107","journal-title":"Eur Urol"},{"key":"4683_CR22","doi-asserted-by":"crossref","unstructured":"Lont AP, Kroon BK, Gallee MP, van Tinteren H, Moonen LM, Horenblas S (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177:947\u201352; discussion 952. doi: S0022\u20135347(06)02740\u20136 [pii]","DOI":"10.1016\/j.juro.2006.10.060"},{"key":"4683_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","volume":"31","author":"J Liu","year":"2013","unstructured":"Liu J, Li Y, Zhang Z, Yao K, Ye Y, Xie D, Han H, Liu Z, Qin Z, Zhou F (2013) The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol 31:1519\u20131524. https:\/\/doi.org\/10.1007\/s00345-013-1024-4","journal-title":"World J Urol"},{"key":"4683_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1464-410X.2009.08450.x","volume":"104","author":"JA Leijte","year":"2009","unstructured":"Leijte JA, Graafland NM, Valdes Olmos RA, van Boven HH, Hoefnagel CA, Horenblas S (2009) Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 104:640\u2013644. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08450.x","journal-title":"BJU Int"},{"key":"4683_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bju.15206","volume":"127","author":"JK Jakobsen","year":"2021","unstructured":"Jakobsen JK, Frahm Nielsen T, Ipsen P, Albrecht-Beste E, Cardoso Costa J, Alslev L, Predbj\u00f8rn Krarup K, Gr\u00f8nkaer Toft B, H\u00f8yer S, Bouchelouche K, Bjerggaard Jensen J (2021) DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography\/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer. BJU Int 127:254\u2013262. https:\/\/doi.org\/10.1111\/bju.15206","journal-title":"BJU Int"},{"key":"4683_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/JU.0000000000000746","volume":"203","author":"M Azizi","year":"2020","unstructured":"Azizi M, Aydin AM, Hajiran A, Lai A, Kumar A, Peyton CC, Minhas S, Sonpavde GP, Chahoud J, Pagliaro LC, Necchi A, Spiess PE (2020) Systematic Review and Meta-Analysis\u2014Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma? J Urol 203:1147\u20131155. https:\/\/doi.org\/10.1097\/JU.0000000000000746","journal-title":"J Urol"},{"key":"4683_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.018","author":"A Sachdeva","year":"2023","unstructured":"Sachdeva A, McGuinness L, Zapala \u0141, Greco I, Garcia-Perdomo H, Kailavasan M, Antunes-Lopes T, Ayres B, Barreto L, Campi R, Crook J, Johnstone P, Kumar V, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Protzel C, Bryan Rumble R, S\u00e1nchez Mart\u00ednez D, F., Spiess PE, Tagawa ST, van der Heijden M, S., Parnham AS, Pettaway CA, Albersen M, Sangar VK, Brouwer OR, Sakalis VI, (2023) Management of Lymph Node-positive Penile Cancer: A Systematic Review. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.018","journal-title":"Eur Urol"},{"key":"4683_CR28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41585-018-0040-y","volume":"15","author":"J Tward","year":"2018","unstructured":"Tward J (2018) The case for nonsurgical therapy of nonmetastatic penile cancer. Nat Rev Urol 15:574\u2013584. https:\/\/doi.org\/10.1038\/s41585-018-0040-y","journal-title":"Nat Rev Urol"},{"key":"4683_CR29","unstructured":"InPACT: International Penile Advanced Cancer Trial Physician and Research Staff Educational Material. In: . https:\/\/ecog-acrin.org\/clinical-trials\/ea8134-educational-materials\/. Accessed April 18, 2023"},{"key":"4683_CR30","unstructured":"European Society of Gynaecological Oncology (ESGO) Vulvar Cancer Guidelines(2023) . In: . https:\/\/www.esgo.org\/media\/2016\/10\/ESGO-Vulvar-cancer-Brochure.pdf. Accessed July 26, 2023"},{"key":"4683_CR31","doi-asserted-by":"publisher","first-page":"641.e9","DOI":"10.1016\/j.urolonc.2020.03.026","volume":"38","author":"J Jaipuria","year":"2020","unstructured":"Jaipuria J, Kohli T, Venkatasubramaniyan M, Singh A, Gupta S, Pathak P, Sharma G, Mitra S, Talwar V, Rawal SK (2020) Adjuvant radiation compares favorably to chemotherapy in patients with carcinoma penis and nodal positivity restricted to groin. Urol Oncol 38:641.e9-641.e18. https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.026","journal-title":"Urol Oncol"},{"key":"4683_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.euf.2018.10.007","volume":"5","author":"PAS Johnstone","year":"2019","unstructured":"Johnstone PAS, Boulware D, Djajadiningrat R, Ottenhof S, Necchi A, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Spiess PE (2019) Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. Eur Urol Focus 5:737\u2013741. https:\/\/doi.org\/10.1016\/j.euf.2018.10.007","journal-title":"Eur Urol Focus"},{"key":"4683_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/bju.15309","volume":"128","author":"M Ager","year":"2021","unstructured":"Ager M, Njoku K, Serra M, Robinson A, Pickering L, Afshar M, Vyas L, Eardley I, Kayes O, Elmamoun M, Khoo V, Ayres B, Henry A, Watkin N, Tree AC (2021) Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis. BJU Int 128:451\u2013459. https:\/\/doi.org\/10.1111\/bju.15309","journal-title":"BJU Int"},{"key":"4683_CR34","doi-asserted-by":"publisher","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","volume":"35","author":"DH Tang","year":"2017","unstructured":"Tang DH, Djajadiningrat R, Diorio G, Chipollini J, Ma Z, Schaible BJ, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Johnstone PAS, Spiess PE (2017) Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study. Urol Oncol 35:605.e17-605.e23. https:\/\/doi.org\/10.1016\/j.urolonc.2017.06.001","journal-title":"Urol Oncol"},{"key":"4683_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","volume":"54","author":"SL Maibom","year":"2020","unstructured":"Maibom SL, Jakobsen JK, Aagaard M, Als AB, Petersen PM (2020) DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation. Scand J Urol 54:334\u2013338. https:\/\/doi.org\/10.1080\/21681805.2020.1776767","journal-title":"Scand J Urol"},{"key":"4683_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ijc.21961","volume":"119","author":"AP Lont","year":"2006","unstructured":"Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, Meijer CJ, Snijders PJ (2006) Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119:1078\u20131081. https:\/\/doi.org\/10.1002\/ijc.21961","journal-title":"Int J Cancer"},{"key":"4683_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand FL, Rasmussen CL, Frederiksen MH, Andersen KK, Kjaer SK (2018) Prognostic Significance of HPV and p16 Status in Men Diagnosed with Penile Cancer: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev 27:1123\u20131132. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0322","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4683_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.euros.2021.12.005","volume":"36","author":"PAS Johnstone","year":"2022","unstructured":"Johnstone PAS, Spiess PE, Sedor G, Grass GD, Yamoah K, Scott JG, Torres-Roca J (2022) Changing Radiotherapy Paradigms in Penile Cancer. Eur Urol Open Sci 36:47\u201348. https:\/\/doi.org\/10.1016\/j.euros.2021.12.005","journal-title":"Eur Urol Open Sci"},{"key":"4683_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0360-3016(92)91062-R","volume":"24","author":"M Delannes","year":"1992","unstructured":"Delannes M, Malavaud B, Douchez J, Bonnet J, Daly NJ (1992) Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 24:479\u2013483","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4683_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0167-8140(95)01574-Z","volume":"36","author":"R Rozan","year":"1995","unstructured":"Rozan R, Albuisson E, Giraud B, Donnarieix D, Delannes M, Pigneux J, Hoffstetter S, Gerbaulet A, Chinet-Charrot P, Goupil A (1995) Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol 36:83\u201393","journal-title":"Radiother Oncol"},{"key":"4683_CR41","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1023\/A:1008248319036","volume":"8","author":"JC Soria","year":"1997","unstructured":"Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Theodore C (1997) Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 8:1089\u20131098","journal-title":"Ann Oncol"},{"key":"4683_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02743456","volume":"175","author":"AJ Chaudhary","year":"1999","unstructured":"Chaudhary AJ, Ghosh S, Bhalavat RL, Kulkarni JN, Sequeira BV (1999) Interstitial brachytherapy in carcinoma of the penis. Strahlenther Onkol 175:17\u201320","journal-title":"Strahlenther Onkol"},{"key":"4683_CR43","first-page":"25","volume":"12","author":"AE Kiltie","year":"2000","unstructured":"Kiltie AE, Elwell C, Close HJ, Ash DV (2000) Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Clin Oncol (R Coll Radiol) 12:25\u201331","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4683_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00345-008-0309-5","volume":"27","author":"J Crook","year":"2009","unstructured":"Crook J, Ma C, Grimard L (2009) Radiation therapy in the management of the primary penile tumor: an update. World J Urol 27:189","journal-title":"World J Urol"},{"key":"4683_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2013.06.001","author":"B Delaunay","year":"2013","unstructured":"Delaunay B, Soh PN, Delannes M, Riou O, Malavaud B, Moreno F, Craven J, Soulie M, Huyghe E (2013) Brachytherapy for penile cancer: Efficacy and impact on sexual function. Brachytherapy. https:\/\/doi.org\/10.1016\/j.brachy.2013.06.001","journal-title":"Brachytherapy"},{"key":"4683_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2015.01.005","author":"A Pimenta","year":"2015","unstructured":"Pimenta A, Gutierrez C, Mosquera D, Pera J, Martinez E, Londres B, Pino F, Moreno S, Garcia M, Guedea F (2015) Penile brachytherapy-Retrospective review of a single institution. Brachytherapy. https:\/\/doi.org\/10.1016\/j.brachy.2015.01.005","journal-title":"Brachytherapy"},{"key":"4683_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.02.090","author":"A Escande","year":"2017","unstructured":"Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, de Crevoisier R, Schernberg A, Marsolat F, Blanchard P, Martinetti F, Bossi A, Dumas I, Deutsch E, Chargari C (2017) Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.02.090","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4683_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(21)01239-1","author":"S Achkari","year":"2020","unstructured":"Achkari S, Bourdais R, Sun R, Kumar T, Kissel M, Felefly T, Minh H, Pounou K, Franck A, Escande A, Deutsch E, Haie-Meder C, Chargari C (2020) Dose-volume predictors of distal urethral toxicity after PDR brachytherapy for penile cancer. Radiother Oncol. https:\/\/doi.org\/10.1016\/S0167-8140(21)01239-1","journal-title":"Radiother Oncol"},{"key":"4683_CR49","doi-asserted-by":"publisher","DOI":"10.14735\/amko201952","author":"D Pohankova","year":"2019","unstructured":"Pohankova D, Sirak I, Kasaova L, Grepl J, Paluska P, Louda M, Holub L, Spacek J, Prosvic P, Petera J (2019) High-dose rate brachytherapy in the treatment of early stages of penile carcinoma. Klin Onkol Winter. https:\/\/doi.org\/10.14735\/amko201952","journal-title":"Klin Onkol Winter"},{"key":"4683_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2014.06.003","author":"DN Sharma","year":"2014","unstructured":"Sharma DN, Joshi NP, Gandhi AK, Haresh KP, Gupta S, Julka PK, Rath GK (2014) High-dose-rate interstitial brachytherapy for T1\u2013T2-stage penile carcinoma: short-term results. Brachytherapy. https:\/\/doi.org\/10.1016\/j.brachy.2014.06.003","journal-title":"Brachytherapy"},{"key":"4683_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-142","author":"Y Rouscoff","year":"2014","unstructured":"Rouscoff Y, Falk AT, Durand M, Gal J, Chand ME, Gautier M, Marsaud A, Chevallier D, Amiel J, Hannoun-Levi JM (2014) High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717X-9-142","journal-title":"Radiat Oncol"},{"key":"4683_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2019.03.006","author":"S Kellas-Sleczka","year":"2019","unstructured":"Kellas-Sleczka S, Bialas B, Fijalkowski M, Wojcieszek P, Szlag M, Cholewka A, Wesolowski M, Sleczka M, Krzysztofiak T, Larysz D, Kolosza Z, Trzaska K, Pruefer A (2019) Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy. Brachytherapy. https:\/\/doi.org\/10.1016\/j.brachy.2019.03.006","journal-title":"Brachytherapy"},{"key":"4683_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2019.12.003","author":"M Marban","year":"2020","unstructured":"Marban M, Crook J, Keyes M, Dubash R, Batchelar D (2020) High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique. Brachytherapy. https:\/\/doi.org\/10.1016\/j.brachy.2019.12.003","journal-title":"Brachytherapy"},{"key":"4683_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2020.12.008","author":"N Martz","year":"2021","unstructured":"Martz N, Bodokh Y, Gautier M, Thamphya B, Schiappa R, Lam Cham Kee D, Chevallier D, Hannoun A, Chand M, Hannoun-Levi J (2021) High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis. Clin Transl Radiat Oncol. https:\/\/doi.org\/10.1016\/j.ctro.2020.12.008","journal-title":"Clin Transl Radiat Oncol"},{"key":"4683_CR55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0936-6555(05)80230-4","volume":"5","author":"F Neave","year":"1993","unstructured":"Neave F, Neal AJ, Hoskin PJ, Hope-Stone HF (1993) Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin Oncol (R Coll Radiol) 5:207\u2013210","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4683_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0360-3016(93)90008-J","volume":"25","author":"M McLean","year":"1993","unstructured":"McLean M, Akl AM, Warde P, Bissett R, Panzarella T, Gospodarowicz M (1993) The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 25:623\u2013628","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4683_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1994.tb09199.x","author":"R Ravi","year":"1994","unstructured":"Ravi R, Chaturvedi HK, Sastry DV (1994) Role of radiation therapy in the treatment of carcinoma of the penis. Br J Urol. https:\/\/doi.org\/10.1111\/j.1464-410x.1994.tb09199.x","journal-title":"Br J Urol"},{"key":"4683_CR58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0360-3016(97)00068-0","volume":"38","author":"R Sarin","year":"1997","unstructured":"Sarin R, Norman AR, Steel GG, Horwich A (1997) Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 38:713\u2013722","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4683_CR59","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000020298","volume":"38","author":"D Gotsadze","year":"2000","unstructured":"Gotsadze D, Matveev B, Zak B, Mamaladze V (2000) Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 38:306\u2013312","journal-title":"Eur Urol"},{"key":"4683_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0959-8049(00)00368-3","volume":"37","author":"A Zouhair","year":"2001","unstructured":"Zouhair A, Coucke PA, Jeanneret W, Douglas P, Do HP, Jichlinski P, Mirimanoff RO, Ozsahin M (2001) Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis? Eur J Cancer 37:198\u2013203","journal-title":"Eur J Cancer"},{"key":"4683_CR61","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ijrobp.2006.05.053","volume":"66","author":"M Ozsahin","year":"2006","unstructured":"Ozsahin M, Jichlinski P, Weber DC, Azria D, Zimmermann M, Guillou L, Bulling S, Moeckli R, Mirimanoff RO, Zouhair A (2006) Treatment of penile carcinoma: to cut or not to cut? Int J Radiat Oncol Biol Phys 66:674\u2013679","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04683-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T12:06:00Z","timestamp":1701518760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4683"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04683-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no relevant financial or non-financial conflicts of interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No research involving humans or animals was conducted for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants, their data or biologic materials"}},{"value":"No consent was required as this is a review of published literature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}